- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT00727935
Comparison Of The Analgesia Obtained By Infiltration For The Joinings Of Episiotomies (Liropep) (LiRoPep)
Comparison Of The Analgesia Obtained By Infiltration Of Lidocaïne 1% And Ropivacaïne 0,75% Versus Placebo For The Joinings Of Episiotomies Among Parturients Under Epidural Analgesia
Lateral episiotomy is a current care practiced with childbirth room. One of the problems encountered with this surgical act is the residual pain on perineal scar level. Maximal during the first 24 hours, this pain can persist several days or several weeks hampering to variable degrees a normal recovery of autonomy and comfort of life. Some studies have shown the interest of ropivacaine, local anaesthetic with a long action's duration for proctologic surgeries and for the cure of inguinal hernia. A recent study shown the ropivacaine perineal infiltration used prior perineorrhaphy allows an absence of post-partum pain for 24 to 27% of cases and a first analgesics request delayed to ten hours.
Methodology: 165 parturients having an epidural analgesia and an episiotomy were enrolled. The perineal infiltration was randomized according to 3 equal groups (placebo, ropivacaine 0,75%, lidocaine 1%) and realised prior perineorrhaphy. then The parturient were followed during the 24 first hours. This study was designed as double blind and the study conduct was standardized in order to get only variable such as the episiotomy infiltration.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Tipo de estudo
Inscrição (Real)
Estágio
- Fase 4
Contactos e Locais
Locais de estudo
-
-
Pays-de-la-Loire
-
Angers, Pays-de-la-Loire, França, 49933
- Centre Hospitalier Universitaire
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Pre-inclusion criteria :
- Assent of participation in the study signed
- Major parturient (> 18 years) in the course of work in room of childbirth
- Mono-foetal pregnancy
- Presentation at the top
Inclusion Criteria:
- Checking of the criteria of pre-inclusion
- Oral confirmation of the assent of the patient
- ASA 1 or 2
- Childbirth by low way
- Patient having an epidural analgesia
- Patient having an episiotomy
- Counter-indication with the ropivacaïne
Pre-exclusion criteria :
- Absence of signed assent of participation in the study
- Counter indication with the lidocaïne
- General counter-indications suitable for the epidural anaesthesia , independently of the local anaesthetic used
- Counter-indications with the infiltration: patient under anticoagulants, coagulopathy
- Allergy to the lidocaine or the ropivacaine
- Allergy to the one of analgesics per bones used in the assumption of responsibility of routine
- Severe insufficiency hepatic and/or renal and/or ulcerates gastro-duodénal (in the case of anti-inflammatory drug regulation not steroid during the postpartum)
- Minor
- Major protected within the meaning of the law Huriet
- Patient during one time of exclusion following another biomedical study
Exclusion Criteria:
- Absence of oral confirmation of the assent of the patient
- Infection or ignition of the point of puncture
- Analgesia epidural not functional
- Dural breach
- Appearance of ascribable side effects to only the anaesthetic buildings at the time of epidural analgesia
- Median Episiotomy (increased risk of lesions of the sphincter)
- Need for an instrumentation at the time of expulsion
- Haemorrhage of the delivery requiring a blood transfusion and/or general anaesthesia in urgency with surgical operation for haemostasis
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Prevenção
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Dobro
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Prazo |
---|---|
Time between the infiltration of the local anaesthetic and the first analgesics catch per os, which is managed when the level of pain evaluated by EVA is higher than 30 mm
Prazo: 1 year
|
1 year
|
Medidas de resultados secundários
Medida de resultado |
Prazo |
---|---|
To compare between the 3 groups the mean level of the pain during the first 24 hours following the joining of the episiotomy, measured by EVA
Prazo: 24 hours
|
24 hours
|
To compare between the 3 groups the analgesics overall consumption per os during the first 24 hours following the joining of the episiotomy
Prazo: 24 hours
|
24 hours
|
To compare between the 3 groups the total cost of the analgesics consumption (local anaesthetic employed and analgesics per bone) during the first 24 hours following the joining of the episiotomy
Prazo: 24 hours
|
24 hours
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Laurent Colbus, MD, Centre Hospitalier Universitaire Angers
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo
Conclusão Primária (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Estimativa)
Atualizações de registro de estudo
Última Atualização Postada (Estimativa)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
- Efeitos Fisiológicos das Drogas
- Mecanismos Moleculares de Ação Farmacológica
- Agentes Antiarrítmicos
- Depressores do Sistema Nervoso Central
- Agentes do Sistema Nervoso Periférico
- Agentes do Sistema Sensorial
- Anestésicos
- Moduladores de transporte de membrana
- Anestésicos Locais
- Bloqueadores de canal de sódio dependentes de voltagem
- Bloqueadores dos Canais de Sódio
- Lidocaína
- Ropivacaína
Outros números de identificação do estudo
- CHU P 2006-03
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .